Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma
-
By
-
Laura B. Oswald
-
Xiaoyin Li
-
Lisa M. Gudenkauf
-
Gabe De Avila
-
David Scheiber-Camoretti
-
Brent J. Small
-
Brian D. Gonzalez
-
Aasha I. Hoogland
-
Oanh Nguyen
-
Yvelise Rodriguez
-
Sylvia L. Crowder
-
Nathan H. Parker
-
Tiffany L. Carson
-
Christine E. Vinci
-
Rachid C. Baz
-
Kenneth H. Shain
-
Brandon Blue
-
Ariel Grajales-Cruz
-
Kristy Matte
-
Brandon Kale
-
David Kaldas
-
Fabiana Perna
-
Melissa Alsina
-
Ciara L. Freeman
-
Omar Castaneda Puglianini
-
Taiga Nishihori
-
Hien Liu
-
Frederick L. Locke
-
Heather S. L. Jim
-
Lauren C. Peres
-
Doris K. Hansen
-
May 11, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Moffitt Cancer Center
Tampa, FL
-
#2
The University of Texas MD Anderson Cancer Center
Houston, TX
-
#3
Wake Forest University School of Medicine
Winston-Salem, NC
-
#4
Clínica Universidad de Navarra
Pamplona, Spain
-
#5
US National Cancer Institute
Bethesda, MD
